Type 2 diabetes patients with no previous cardiovascular disease who were on low-dose aspirin treatment did not show a lower risk of cardiovascular disease or death at 3.9 years compared with nonusers, according to a study in BMJ Open. Researchers noted a slightly increased risk of both fatal and nonfatal heart disease in female aspirin users compared with women who did not take the drug.
Aspirin may not provide benefits for type 2 diabetes patients
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||